CreativeOne Wealth LLC Buys New Position in Astera Labs, Inc. $ALAB

CreativeOne Wealth LLC purchased a new position in Astera Labs, Inc. (NASDAQ:ALAB) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 4,216 shares of the company’s stock, valued at approximately $381,000.

A number of other hedge funds have also recently modified their holdings of the business. Oliver Lagore Vanvalin Investment Group bought a new position in Astera Labs in the 2nd quarter worth $29,000. Bernard Wealth Management Corp. purchased a new stake in Astera Labs in the second quarter worth about $36,000. Clearstead Trust LLC raised its stake in shares of Astera Labs by 46,100.0% in the second quarter. Clearstead Trust LLC now owns 462 shares of the company’s stock worth $42,000 after buying an additional 461 shares during the period. Ameritas Advisory Services LLC purchased a new position in shares of Astera Labs during the 2nd quarter valued at about $64,000. Finally, Harbour Investments Inc. lifted its position in shares of Astera Labs by 351.7% during the 1st quarter. Harbour Investments Inc. now owns 795 shares of the company’s stock valued at $47,000 after buying an additional 619 shares in the last quarter. Institutional investors own 60.47% of the company’s stock.

Astera Labs Trading Up 2.1%

Shares of ALAB stock opened at $157.54 on Friday. The stock has a market capitalization of $26.61 billion, a price-to-earnings ratio of 141.92, a price-to-earnings-growth ratio of 2.94 and a beta of 1.37. Astera Labs, Inc. has a 12-month low of $47.13 and a 12-month high of $262.90. The stock’s 50-day moving average price is $175.95 and its 200-day moving average price is $148.90.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings results on Tuesday, November 4th. The company reported $0.49 EPS for the quarter, beating analysts’ consensus estimates of $0.39 by $0.10. The company had revenue of $230.58 million during the quarter, compared to analyst estimates of $206.42 million. Astera Labs had a return on equity of 13.48% and a net margin of 27.50%.The firm’s revenue was up 103.9% on a year-over-year basis. During the same period in the prior year, the company earned $0.23 earnings per share. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. As a group, research analysts predict that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Insider Activity

In related news, CEO Jitendra Mohan sold 90,459 shares of the company’s stock in a transaction on Monday, November 17th. The shares were sold at an average price of $144.69, for a total transaction of $13,088,512.71. Following the sale, the chief executive officer owned 2,080,418 shares of the company’s stock, valued at $301,015,680.42. This represents a 4.17% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, General Counsel Philip Mazzara sold 10,000 shares of Astera Labs stock in a transaction on Wednesday, October 1st. The stock was sold at an average price of $192.16, for a total transaction of $1,921,600.00. Following the completion of the transaction, the general counsel directly owned 151,573 shares of the company’s stock, valued at $29,126,267.68. The trade was a 6.19% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 586,936 shares of company stock worth $90,628,610. 12.50% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of equities research analysts have commented on ALAB shares. Barclays restated an “equal weight” rating and set a $155.00 target price on shares of Astera Labs in a research note on Monday, October 20th. Northland Securities set a $175.00 price objective on shares of Astera Labs in a research report on Monday, November 17th. BNP Paribas initiated coverage on shares of Astera Labs in a research note on Thursday, November 20th. They set an “outperform” rating on the stock. Roth Capital increased their price target on Astera Labs from $200.00 to $225.00 and gave the stock a “buy” rating in a research note on Wednesday, November 5th. Finally, JPMorgan Chase & Co. boosted their price objective on Astera Labs from $180.00 to $215.00 and gave the company an “overweight” rating in a research report on Wednesday, November 5th. One analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and eight have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $187.06.

Astera Labs Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.